Healthcare Industry News Weekly Wrap-Up: September 9, 2022
// Biotech and Pharma Therapeutics Bayer, Regeneron’s eye drug shown to work at higher dose, longer intervals September 8, 2022 / Age-related Macular Degeneration / Diabetic Macular Oedema Bayer (BAYGn.DE)said on Thursday its anti-blindness treatment Eylea, jointly developed with Regeneron...